Menu Search
Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

Actions
  • Price (GBX)358.00
  • Today's Change-2.00 / -0.56%
  • Shares traded131.17k
  • 1 Year change+7.67%
  • Beta0.6473
Data delayed at least 20 minutes, as of Apr 19 2024 16:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PricePolar Capital Global Healthcare Trust (Ordinary Share)+9.85%
NAVPolar Capital Global Healthcare Trust (Ordinary Share)+9.30%
Morningstar's BenchmarkMSCI ACWI/Health Care NR GBP enhanced--
--
More ▼

Key statistics

On Friday, Polar Capital Global Healthcare Trust (PCGH:LSE) closed at 358.00, -5.54% below its 52-week high of 379.00, set on Apr 03, 2024.
52-week range
Today
294.00Nov 07 2023379.00Apr 03 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding121.27m
Market cap436.57m GBP
Total assets503.42m GBP
Total expense ratio0.94%
High359.00
Low357.00
Previous close360.00
Average volume188.69k
YTD Change+8.48%
Beta0.6473
Diluted NAV (est)384.04
Diluted NAV (last pub)382.70
Premium/Discount-6.78%
Net Gearing+7.43%
Annual div (ADY)2.20
GBX
Annual div yield (ADY)0.61%
Div ex-dateFeb 01 2024
Div pay-dateFeb 29 2024
Data delayed at least 20 minutes, as of Apr 19 2024 16:28 BST.
More ▼

Annual Reports

Board of Directors

1/4

Lisa Arnold, Chairman

2/4

Neal Ransome, Director

3/4

Andrew Fleming, Director

4/4

Jeremy Whitley, Director

Further Information

Contact

The Company Secretary can be contacted at the Registered Office.

Registered Office:
16 Palace Street
London
SW1E 5JD

T: +44 (0) 20 7227 2700
F: +44 (0) 20 7227 2799
E: investor-relations@polarcapital.co.uk
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.